Daniel Pregibon

Daniel Pregibon is a life sciences entrepreneur and current Head of Platform Discovery and Technology at Repertoire Immune Medicines. With a strong technical background in microfluidics, materials, and biomolecule analysis, they have successfully managed new product development and led significant innovations in the field. Daniel previously served as General Manager of Platform Innovation at Abcam, where they advanced the FirePlex Platform, and co-founded Firefly BioWorks, Inc., overseeing critical developments and securing funding. Their work has resulted in a solid publication record with an h-index of 14 and 15 patent families, of which 9 patents have been issued or allowed. They also hold a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology.